Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
Opexa Therapeutics, Inc.
Commercial Physical And Biological Research TX, United States
Company Description
Opexa Therapeutics, Inc. is a biopharmaceutical company developing personalized cellular therapies with the potential to treat major illnesses, including multiple sclerosis. These therapies are based on its proprietary T-cell technology. The Tovaxin is a personalized T-cell vaccine for the treatment of multiple sclerosis that is specifically tailored to each patient's disease profile. The company was founded on 2004 and is headquartered in The Woodlands, TX.
Similar to: Exelixis, Inc., Advanced Cell Technology, Inc., Medivir AB
Featured Company
Goodwin Plc
Hanley, ST, GB
Goodwin Plc provides machining, general engineering, valves and Pumps. The firm operates casting, melting, refining, assembly and… Learn more →
Social Monitor
You may also be interested in:
Medivir AB
Stockholm, SE
Medivir is a research based pharmaceutical company focused on infectious diseases and Nordic market presences were we market 15 products… Learn more →
Advanced Cell Technology,…
Marlborough, MA, US
Advanced Cell Technology, Inc. is a biotechnology company that develops cellular therapies for the treatment of rare and common diseases… Learn more →
Exelixis, Inc.
South San Francisco, CA, US
Exelixis, Inc. develops human therapeutics by innovating therapies for cancer and other serious diseases to various pharmaceutical… Learn more →